The US Federal Trade Commission said that CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum ...

These snack recipes are lower in sodium, saturated fat, carbs and calories, making them good choices for managing insulin ...

Ypsomed reports positive outcomes from a randomized trial of its closed-loop insulin delivery technology during type 1 ...

Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

MADRID — The de-escalation of a multiple daily injection regimen of insulin for type 2 diabetes to a once-daily fixed-ratio combination of insulin glargine U100 and glucagon-like peptide 1 receptor ...

In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

Tirzepatide for diabetes vs long-acting insulins demonstrated superior glycemic control and weight loss compared among adults with type 2 diabetes.

AIDS Healthcare Foundation (AHF) applauds the U.S. Federal Trade Commission (FTC) for taking decisive action against pharmacy benefit managers (PBMs) that drive up costs for insulin, a product never ...

Sen. Mike Braun has a unique opportunity to hold Novo Nordisk accountable for discontinuing insulin drug Levemir.

Caremark, Express Scripts, Optum and their GPOs created a rebate system that boosted PBM profits, FTC alleges.